Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5572160 | Clinical Nutrition | 2017 | 47 Pages |
Abstract
Little work has been done exploring the role for omega-3 PUFAs in oesophageal cancer prevention and management. The authors are conducting a clinical trial investigating the use of parenteral omega-3 PUFAs supplementary to the standard of care (epirubicin, oxaliplatin and capecitabine palliative chemotherapy) in patients with advanced oesophagogastric cancer as a promising new therapeutic approach.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
A.M. Eltweri, A.L. Thomas, M. Metcalfe, P.C. Calder, A.R. Dennison, D.J. Bowrey,